Literature DB >> 8905601

Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women.

S Senöz1, B Direm, B Gülekli, O Gökmen.   

Abstract

UNLABELLED: The protective effect of estrogen against cardiovascular diseases (CVD) in women disappears after menopause. However, it is not clear whether the change in risk factors after menopause is related to aging or estrogen deprivation.
OBJECTIVE: To assess the risks for CVD and the contribution of aging in estrogen-deprived women.
METHODS: Forty-one patients with premature ovarian failure (POF) (group 1) and 30 patients with natural menopause (group 2) were investigated with respect to well-known risk factors for CVD. Fifteen young women at reproductive age (group 3) were taken as controls. The median ages (ranges) of the groups were 31 (19-40), 52 (46-67) and 26 (24-29) years, respectively. Family and personal history for CVD, smoking, oral contraceptive usage, physical examination, blood pressure measurement, body mass index (BMI), blood level of fasting insulin, diabetes mellitus, and the levels of lipoprotein proteins were the examined parameters regarding the risks for CVD.
RESULTS: The levels of triglycerides and very low density lipoprotein (VLDL) cholesterol were not different in the 3 groups. The levels of fasting insulin (11.3 +/- 6.6 vs. 10.2 +/- 5.8 IU/ml), the ratio of fasting insulin to fasting blood glucose (12.2 +/- 6.3% vs. 10.5 +/- 5.4%), high density lipoprotein (HDL) cholesterol (51.9 +/- 12.9 vs. 51.6 +/- 9.7 mg/d), low density lipoprotein (LDL) cholesterol (113 +/- 47 vs. 127 +/- 37 mg/dl) and the ratio of HDL to total cholesterol (27.2 +/- 9.8% vs. 24.1 +/- 6.9%) were not different in women with POF and natural menopause. These parameters were all better in controls with respect to risk for CVD (respectively, 6.5 +/- 2.0 IU/ml, 7.4 +/- 2.2%, 37.9 +/- 5.3 mg/dl, 80 +/- 40 mg/dl, P < 0.05).
CONCLUSION: Risk factors for CVD are related to estrogen deprivation. Aging does not have an important impact on CVD within the age range of this study group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905601     DOI: 10.1016/0378-5122(96)01051-1

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  3 in total

Review 1.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

2.  Estrogens and neuropeptides in postmenopausal women: un update.

Authors:  M Guida; F Zullo; B Buonomo; M L Marra; V Palatucci; R Pascale; F Visconti; G Guerra; Ml Spinelli; A Di Spiezio Sardo
Journal:  Transl Med UniSa       Date:  2012-04-30

3.  Gender-dependent association of HSD11B1 single nucleotide polymorphisms with glucose and HDL-C levels.

Authors:  Luciane Viater Turek; Neiva Leite; Ricardo Lehtonen Rodrigues Souza; Jovana Karoline Lima; Gerusa Eisfeld Milano; Luciana da Silva Timossi; Ana Claudia Vecchi Osiecki; Raul Osiecki; Lupe Furtado Alle
Journal:  Genet Mol Biol       Date:  2014-09       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.